Immunoconjugates [CS] - M0028142

Name: Table of NDC products with immunoconjugates
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	M0028142
Pharmacologic Name	Immunoconjugates
Pharmacologic Uses	CD22-directed antibody-drug conjugate (ADC) CD2-directed LFA-3/Fc fusion protein CD30-directed antibody-drug conjugate
Pharmacologic Concept	Chemical Structure - [CS]
Pharmacologic Concept Description	This concept refers to the chemical structure and classification containing chemicals or other drug ingredients, organized into a chemical structure classification hierarchy.

NDC Products with Immunoconjugates

The table contains 2 products whose active ingredient are classified under the same pharmacologic class Immunoconjugates [CS].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0008-0100	Besponsa	Non-Proprietary Name: Inotuzumab Ozogamicin	Injection, Powder, Lyophilized, For Solution	Intravenous	Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.	ACTIVE
	51144-050	Adcetris	Non-Proprietary Name: Brentuximab Vedotin	Injection, Powder, Lyophilized, For Solution	Intravenous	Seagen Inc.	ACTIVE